Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2014

Nov 14, 2014

5262_dirs_2014-11-14_2f7d1804-3a55-42b0-8aee-1ee29e7f2f42.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0905X

GlaxoSmithKline PLC

14 November 2014

As a result of an administrative error by the Company's external share plan administrator, in connection with the number of shares actually sold, this announcement replaces the original announcement released on 23 October 2014 at 17:26 (RNS No: 1732V).

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

In accordance with DTR 3.1.4R(1)(a) I give below details of changes in the interests of Sir Andrew Witty, a Director, in the Ordinary Shares of GlaxoSmithKline plc (the "Company"):

The exercise of options over 77,500 Ordinary Shares on 23 October 2014, granted on 2 December 2004 under the GlaxoSmithKline Share Option Plan at a price of £11.23 per share, and the sale of 69,905 Ordinary Shares at a price of £13.84 per share on 23 October 2014.

The Company was advised of the revised transaction details on 13 November 2014.

V A Whyte

Company Secretary

14 November 2014

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSBDBDBGXBBGSS